Originally published on 2 May 2024. Kept as written; the law it describes may have moved since.
The Johnson & Johnson Tylenol crisis of 1982 is often portrayed as a classic management dilemma – risk vs. profit. But there's another important layer: the power of core values in decision-making.
While production goals undoubtedly drive organizations, leaders constantly navigate the tension between performance and risk mitigation. In high-pressure environments, this can create an unconscious bias towards productivity over other priorities. When this happens, the only way to rebalance the scale is through strongly established, clearly demonstrated core values like safety or integrity.
In the Tylenol crisis, Johnson & Johnson found itself at this crossroads. Despite immense pressure, the CEO's choice to globally recall Tylenol prioritized customer safety. This signaled deeply embedded values within the company's leadership ranks. Any choice compromising customer safety, even for the sake of profits, would have been a fundamental contradiction of those values.
Ultimately, while the Tylenol case raises complex ethical questions, it's also a powerful example of value-driven decision-making. The CEO's actions put safety over short-term profits, demonstrating a principled leadership approach.